Off-Beat Holiday Club v Sanbonani Holiday Spa Share Block Limited

The appellants (Off-Beat Holiday Club and Flexi Holiday Club) were minority shareholders owning 29.14% of shares in Sanbonani Holiday Spa Share Block Limited (Shareblock), a timeshare and share block resort company. The third respondent, Mr Hans Michael Harri, was a director and majority shareholder/controller of Shareblock. The appellants alleged various wrongs by Harri including: (i) wrongful payment of VAT refunds totaling approximately R2.3 million to related entities controlled by Harri; (ii) improper allocation of shares in Shareblock; (iii) construction of hotel facilities contrary to registered plans for Harri's exclusive benefit; (iv) non-payment of levies by entities controlled by Harri; and (v) manipulation of financial statements. These disputes arose from events occurring between 1987-2000, with the appellants aware of them by at least 2003. The appellants launched proceedings in October 2008 under sections 252 and 266 of the Companies Act 61 of 1973, seeking appointment of a curator ad litem and declarations regarding the validity of certain articles and share allocations. A curator was provisionally appointed, investigated, and recommended that Shareblock take action against Harri. The High Court confirmed the curator's appointment for certain claims but dismissed others as prescribed.

• Whether claims brought by minority shareholders under sections 252 and 266 of the Companies Act 61 of 1973 constitute 'debts' susceptible to extinctive prescription under the Prescription Act 68 of 1969
• Whether section 13(1)(e) of the Prescription Act prevents prescription where the debtor is a director of the creditor company
• Whether a shareholder's right to institute derivative proceedings under section 266 prescribes independently of the company's underlying claim
• Whether claims for declaratory relief under section 252 regarding validity of company articles are susceptible to prescription
• The distinction between real rights and personal rights for purposes of prescription
• Whether rectification-type claims are analogous to claims challenging validity of company articles

The application for condonation was granted, with the appellants ordered to pay wasted costs. Leave to appeal was granted. The appeal was upheld in part. The order of the High Court was amended by adding to paragraphs 3 and 4 a sub-paragraph (iii) which reads: "the fact that the third respondent has wrongfully allowed or caused the first respondent to unjustifiably pay VAT refunds in the sums of R2 169 897.04 and R120 309.13 to the second respondent." Costs of the appeal, including those for two counsel, were awarded to the appellants.

The binding legal principles established are: (1) A claim brought under section 266 of the Companies Act 61 of 1973 is a statutory derivative action in which the company is the creditor and the delinquent director is the debtor; the shareholder merely vindicates the company's claim. (2) A shareholder's right to invoke section 266 to appoint a curator ad litem has no correlative debt within the meaning of the Prescription Act and therefore does not itself prescribe. (3) Where section 13(1)(e) of the Prescription Act applies (creditor is a juristic person and debtor is a member of its governing body), the debt owed to the company does not prescribe while the impediment exists. (4) A shareholder's entitlement to bring derivative proceedings under section 266 remains extant as long as the company's underlying claim has not prescribed. (5) The debt owed by the delinquent director to the company arises only when the court confirms the curator's appointment under section 266(4) to institute proceedings, or when the director ceases to be a member of the governing body. (6) Claims under section 252 relating to the validity of company articles and share allocations constitute personal rights arising from the contractual relationship created by the company's constitutional documents and are susceptible to prescription. (7) Such claims are distinguishable from rectification claims because they would alter parties' rights and obligations rather than merely correcting an erroneous recording of existing rights.

The Court made several non-binding observations: (1) Maya ADP noted that the Uniform Rules and Supreme Court of Appeal Rules may permit multiple applications for leave to appeal in extraordinary circumstances where the interests of justice demand it, though this was assumed rather than decided. (2) The Court observed the unfortunate trend of piecemeal filing of appeal documents and proliferation of documents meant to patch a party's case. (3) The Court commented on the "unprecedented piecemeal approach" of filing several notices of application for leave to appeal. (4) Cachalia JA posed rhetorical questions about potential anomalies if shareholder claims under section 266 were capable of independent prescription: what would happen with multiple shareholders, if delays affected only some shareholders, or if shares were sold to new shareholders? (5) Leach JA noted it was unnecessary to decide whether prescription only starts running once a curator is appointed, though he did not necessarily disagree with that conclusion. (6) The Court described the history of disputes between the parties as having "dogged" the shareblock and resort for many years, characterizing them as "a series of legal skirmishes."

This case is significant for establishing important principles regarding prescription in the context of minority shareholder remedies under the Companies Act. It clarifies that: (1) Section 13(1)(e) of the Prescription Act prevents prescription of debts owed by a director to a company while the director remains on the governing body. (2) A shareholder's statutory right to bring derivative proceedings under section 266 does not prescribe independently of the underlying company claim - the shareholder's entitlement remains alive as long as the company's claim is extant. (3) The case distinguishes between true rectification claims (which do not create debts susceptible to prescription) and claims that would alter parties' rights and obligations (which do). (4) It reaffirms the derivative nature of section 266 actions, emphasizing that the company, not the shareholder, is the creditor in such claims. The judgment provides important guidance on when minority shareholders can pursue claims on behalf of companies despite the passage of time, protecting shareholders from being time-barred while the wrongdoer remains in control of the company.